Directory
>
Blair Madison
Blair Madison
Chief Scientific Officer, Gene Therapy | Poseida Therapeutics, Inc.
San Diego, California, United States
Blair Madison
Summary
Blair Madison is an accomplished Chief Scientific Officer with over 20 years of experience in the fields of biochemistry and cancer genomics. Currently leading gene therapy initiatives at Poseida Therapeutics, he has a strong background in transposon research and applications, particularly with the PiggyBac system. Blair has pioneered innovative techniques in CRISPR technology, enhancing gene editing capabilities across various cell types. His academic journey includes a PhD from the University of Michigan and a BA from Washington University in St. Louis. With a robust publication history, he is deeply engaged in advancing the understanding of microRNAs and their roles in cancer biology. Blair's leadership extends beyond research, as he has held multiple executive roles, driving strategic initiatives in biopharmaceutical development. His commitment to scientific excellence is matched by his passion for mentoring the next generation of scientists.
Blair Madison
Work Experience
Chief Scientific Officer, Gene Therapy at
Poseida Therapeutics, Inc.
February 2023 - Present
Vice President at
Poseida Therapeutics, Inc.
February 2022 - February 2023
Executive Director at
Poseida Therapeutics, Inc.
October 2021 - February 2022
Senior Director at
Poseida Therapeutics, Inc.
November 2019 - October 2021
Assistant Professor at
Washington University In St Louis
August 2014 - November 2019
Postdoctoral Fellow at
University of Pennsylvania
January 2009 - January 2014
Vice President, Research at
Transposagen Biopharmaceuticals
January 2007 - January 2009
Postdoctoral Researcher at
University of Pennsylvania
January 2006 - October 2007
Blair Madison
Education
University of Michigan, Doctor Of Philosophy - Phd
January 1999 - January 2005
Washington University in St. Louis, Bachelor Of Arts - Ba
January 1994 - January 1998
Frequently Asked Questions about Blair Madison
What is Blair Madison email address?
Blair Madison's primary email address is ********@poseida.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Blair Madison work for?
Blair Madison is a Chief Scientific Officer, Gene Therapy at Poseida Therapeutics, Inc., a company specializing in Commercial physical research.
Where Blair Madison graduated from?
Blair Madison holds a degree in Cell/Cellular And Molecular Biology from University of Michigan.
How can I directly contact Blair Madison?
To contact Blair Madison directly, you can use the email address ********@poseida.com. Complete contact information is available upon registration with Muraena.
Who is Blair Madison?
Blair Madison is an accomplished Chief Scientific Officer with over 20 years of experience in the fields of biochemistry and cancer genomics. Currently leading gene therapy initiatives at Poseida Therapeutics, he has a strong background in transposon research and applications, particularly with the PiggyBac system. Blair has pioneered innovative techniques in CRISPR technology, enhancing gene editing capabilities across various cell types. His academic journey includes a PhD from the University of Michigan and a BA from Washington University in St. Louis. With a robust publication history, he is deeply engaged in advancing the understanding of microRNAs and their roles in cancer biology. Blair's leadership extends beyond research, as he has held multiple executive roles, driving strategic initiatives in biopharmaceutical development. His commitment to scientific excellence is matched by his passion for mentoring the next generation of scientists.
Blair`s contact details
********@poseida.com
********@umich.edu
Colleagues
Vice President, Head of Statistical and Data Sciences
General Counsel, Chief Compliance Officer & Corporate Secretary
Vice President, Information Technology
Chief People & Administration Officer
Senior Vice President Regulatory Affairs
Vice President, Cinical Development
Vice President R&D, Gene Therapy
Vice President of Immuno-Oncology
VP, Intellectual Property
Executive Chairman